护肝益肺颗粒防治抗结核药所致肝损害的临床疗效观察(临床医学范文).docVIP

护肝益肺颗粒防治抗结核药所致肝损害的临床疗效观察(临床医学范文).doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
护肝益肺颗粒防治抗结核药所致肝损害的临床疗效观察(临床医学范文) 文档信息 : 文档作为关于“医学心理学”中“骨科学”的参考范文,为解决如何写好实用应用文、正确编写文案格式、内容素材摘取等相关工作提供支持。正文6579字,doc格式,可编辑。质优实惠,欢迎下载! 目录 TOC \o 1-9 \h \z \u 目录 1 正文 1 文1:护肝益肺颗粒防治抗结核药所致肝损害的临床疗效观察 1 1资料和方法 3 1.3药物性肝损害诊断及疗效判定标准 3 文2:护肝益肺颗粒防治抗结核药所致肝损害的临床疗效观察 4 1资料和方法 5 1.3药物性肝损害诊断及疗效判定标准 6 参考文摘引言: 7 原创性声明(模板) 8 文章致谢(模板) 8 正文 护肝益肺颗粒防治抗结核药所致肝损害的临床疗效观察(临床医学范文) 文1:护肝益肺颗粒防治抗结核药所致肝损害的临床疗效观察 Study on the Function of the Granule of Huganyifei on Hepatic Iufficiency Induced by the Drugs for TB Abstract:Objective:To study the function of the Granule of Huganyifei to treat the TB patients who has hepatic iufficiency, and the treatment action to pulmonary tuberculosis.Methods:646 patients were divided into five groups : the prevent treatment group (205 patients) , the prevent contrast treatment group (208 patients), the contrast group(126 patients ) , the treatment group with hepatic iufficiency(52 patients), and the contrast group with hepatic iufficiency(55 patients). All of the treatment groups without hepatic iufficiency were administered INH, PZA, RFP for two months. The prevent treatment group was added the Granule(4 g, three times a day). The prevent contrast treatment group was added Glucurone(0.2 g, three times a day). The contrast group was added nothing. The treatment group with hepatic iufficiency used the Granule for one month (8 g, three times a day) , the contrast group with hepatic iufficiency had used Oleanolic Acid (60 mg, three times a day) and Huganpian ( 4 pieces, three times a day ) for one month.Results:The proportion of the patients who had hepatic iufficiency of the prevent treatment group was 1.9%, the prevent contrast treatment group was 4.8%, and the contrast group was 7.1%. The show effect proportion of the treatment group with hepatic iufficiency was 76.5%, the contrast group with hepatic iufficiency was 40%. There was notable difference between the two groups (P0.01). Conclusion:The Granule of Huganyifei can reduce the pr

您可能关注的文档

文档评论(0)

asen1997 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档